Mirum Pharmaceuticals, Inc. MIRM Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accrued expenses?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued expenses of $35.43M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued expenses increased by 113.5% year-over-year, from $16.6M to $35.43M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s accrued expenses has grown at a 28.7% compound annual growth rate (CAGR), from $13.41M to $47.28M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.